The importance of the C677T MTHFR mutation to promote neural tube defects is also well recognized [44,45]; similarly, the preventative effect of low-dose folate administration on stroke onset has been repeatedly confirmed [46]; these findings are consistent with the higher plasma levels of homocysteine found in PFO carriers [26]. This evidence concerns the gene MTHFR and Stroke.